default author photo

Richard Beatson

King’s College London - Guy’s Cancer Centre

London

United Kingdom

King’s College London - School of Cancer and Pharmaceutical Sciences

SCHOLARLY PAPERS

2

DOWNLOADS

84

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

TGF-β1 Potentiates Adoptive Immunotherapy of Hematological and Solid Tumors Using ex vivo Expanded γδ T-Cells

Number of pages: 60 Posted: 01 Jun 2021
King’s College London - Guy’s Cancer Centre, King’s College London - Guy’s Cancer Centre, King's College London - Guy's Cancer Centre, National Institute for Health Research (NIHR) Biomedical Centre - Translational Bioinformatics, King’s College London - Guy’s Cancer Centre, King's College London - Guy's Cancer Centre, King’s College London - Guy’s Cancer Centre, King’s College London - Guy’s Cancer Centre, King’s College London - Guy’s Cancer Centre, King's College London - Guy's Cancer Centre, King’s College London - Guy’s Cancer Centre, King’s College London - Guy’s Cancer Centre, King’s College London - Guy’s Cancer Centre, King's College London - School of Biomedical Engineering and Imaging Sciences, King's College London - School of Biomedical Engineering and Imaging Sciences, Bayer Healthcare Innovation Center, Bayer Healthcare Innovation Center, King's College London - Guy's Cancer Centre, King’s College London - Guy’s Cancer Centre, King’s College London - Guy’s Cancer Centre, Bayer AG, Bayer AG, Semmelweis University - TTK Cancer Biomarker Research Group and Department of Bioinformatics, King’s College London - Guy’s Cancer Centre, King's College London - Guy's Cancer Centre, Bayer AG, King's College London - Guy’s Cancer Centre, Breast Cancer Now Unit, King's College London - Guy's Cancer Centre and Guy's Hospital - Leucid Bio Ltd.
Downloads 58 (980,173)

Abstract:

Loading...

2.

LYVE-1 + Macrophages Form a Collaborative CCR5-Dependent Perivascular Niche That Influences Chemotherapy Responses in Cancer

Number of pages: 61 Posted: 07 Jul 2022
King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - Centre for Stem Cells and Regenerative Medicine, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - Guy’s Cancer Centre, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, The University of Hong Kong - School of Biomedical Sciences, University of Cambridge - Cancer Research UK Cambridge Institute, King’s College London - Centre for Stem Cells and Regenerative Medicine, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, University of Birmingham, King’s College London - Centre for Inflammation Biology and Cancer Immunology and King’s College London - School of Cancer and Pharmaceutical Sciences
Downloads 26 (1,372,601)

Abstract:

Loading...

Tumor, macrophage, TAM subset development, perivascular niche, spatial, CCR5, LYVE-1, chemotherapy resistance, immune exclusion